Open AccessClinical Risk Factors and Timing of Recurrent Venous Thromboembolism During the Initial 3 Months of Anticoagulant Therapy
Author(s) -
James D. Douketis,
Gary Foster,
Mark Crowther,
Martin H. Prins,
J S Ginsberg
Publication year - 2000
Publication title -
archives of internal medicine
Language(s) - English
Resource type - Journals
eISSN - 1538-3679
pISSN - 0003-9926
DOI - 10.1001/archinte.160.22.3431
Subject(s) - medicine , pulmonary embolism , odds ratio , deep vein , confidence interval , venous thrombosis , thrombosis , anticoagulant therapy , anticoagulant , surgery
In patients with venous thromboembolism (VTE), identifying clinical risk factors for recurrence during the initial 3 months of anticoagulant therapy and knowledge of the time course of recurrence may help clinicians decide about the frequency of clinical surveillance and the appropriateness of outpatient treatment.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom